The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
The biotechnology company will tap into Catalent’s expertise in induced pluripotent stem cells and advanced cell-therapy manufacturing
Salanersen was generally well-tolerated, slowed neurodegeneration, and enabled functional gains
The conflict is also triggering a widening public health emergency
The agreement brings to market a method pioneered at CU Boulder that enables the reliable synthesis of long RNA strands
The first of four planned modules at the new plant is expected to come online by summer 2026
Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
Recent data reveal that patients undergoing MWL are entering aesthetic practices with unique needs tied to facial structure and skin quality
The company has shown remarkable growth, posting a three-year CAGR of around 75% with an ARR of roughly Rs 100 crore and impressive gross margins
Subscribe To Our Newsletter & Stay Updated
